Open
X

Posts Tagged 'FDA'

PCSK9 Inhibitors: Why Are They Under-Prescribed?

by Seth J. Baum, MD A recent article by Caroline Humer and Ransdell Pierson for Reuters reported on the unexpectedly paltry number of prescriptions for PCSK9 inhibitors, the revolutionary cholesterol.. read more

FDA Gives Premarket Approval for Modification of LDL Indications for Use of Lipoprotein Apheresis System

Posted on July 21st, 2015 · Posted in cardiology, News

by Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA The FDA has granted premarket approval to Kaneka Pharma America’s application requesting approval for modification of the indications for use of.. read more